Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study

PurposeThe need for adjuvant therapy (AT) following neoadjuvant chemoimmunotherapy (nICT) and surgery in esophageal squamous cell cancer (ESCC) remains uncertain. This study aims to investigate whether AT offers additional benefits in terms of recurrence-free survival (RFS) for ESCC patients after n...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Shu-Han Xie, Li-Tao Yang, Hai Zhang, Zi-Lu Tang, Zhi-Wei Lin, Yi Chen, Zhi-Nuan Hong, Rong-Yu Xu, Wan-Li Lin, Ming-Qiang Kang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	adjuvant therapy neoadjuvant chemoimmunotherapy esophageal cancer propensity score matching recurrence-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1332492/full

Similar Items

Application of machine learning based on habitat imaging and vision transformer to predict treatment response of locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a multi-center study
by: Shu-Han Xie, et al.
Published: (2025-08-01)

Indocyanine Green Fluorescence Using in Conduit Reconstruction for Patients With Esophageal Cancer to Improve Short-Term Clinical Outcome: A Meta-Analysis
by: Zhi-Nuan Hong, et al.
Published: (2022-06-01)

Editorial: Frontiers' research topic “advances in esophageal cancer surgery with neoadjuvant therapies”
by: Qi-Xin Shang, et al.
Published: (2023-11-01)

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study
by: Shuhan Xie, et al.
Published: (2025-07-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy
by: Rong Liu, et al.
Published: (2024-01-01)

Comparison of different exercise modalities on fatigue and muscular fitness in patients with multiple sclerosis: a systematic review with network, and dose–response meta-analyses
by: Xi-Nuan Zhang, et al.
Published: (2024-11-01)

The effect of valve noise on the quality of life of patients after mechanical mitral valve replacement in a Chinese population
by: Zhi-Nuan Hong, et al.
Published: (2019-07-01)

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
by: Lang X, et al.
Published: (2024-05-01)

Health-related quality of life in adults undergoing transthoracic device closure of ventricular septal defect
by: Kai-Peng Sun, et al.
Published: (2019-10-01)

Surgical repair via submammary thoracotomy, right axillary thoracotomy and median sternotomy for ventricular septal defects
by: Zhi-Nuan Hong, et al.
Published: (2018-05-01)

A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
by: Leilei Wang, et al.
Published: (2024-05-01)

Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma
by: Liang Zheng, et al.
Published: (2025-04-01)

Association Between Antibiotic and Outcomes of Chemoimmunotherapy for Extensive‐Stage Small Cell Lung Cancer: A Multicenter Retrospective Study of 132 Patients
by: Fang Deng, et al.
Published: (2025-01-01)

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
by: Ye Wang, et al.
Published: (2024-04-01)

Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China
by: Jinxin Xu, et al.
Published: (2024-02-01)

MRI-based texture analysis for the evaluation of the response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma
by: Haoran Wei, et al.
Published: (2025-07-01)

Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
by: Manxiu Huai, et al.
Published: (2024-05-01)

Impacts of the Major Drought in Chile and Mitigation Measures
by: Xu Nuan
Published: (2023-01-01)

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
by: Gao F, et al.
Published: (2015-06-01)

Crystal structure of (E)-2-((3-fluoropyridin-4-yl)methylene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
by: Wang Chen, et al.
Published: (2021-09-01)

Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
by: Zhi-Nuan Hong, et al.
Published: (2021-12-01)

In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response
by: Qin Liu, et al.
Published: (2024-04-01)

Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma
by: Lizao Zhang, et al.
Published: (2025-12-01)

Early kinetics of serum amyloid A predict clinical benefit to first-line chemoimmunotherapy and immunotherapy in advanced non-small cell lung cancer: a retrospective analysis
by: Wei Du, et al.
Published: (2025-05-01)

Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
by: Xiao Liu, et al.
Published: (2024-04-01)

ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
by: Chao He, et al.
Published: (2025-04-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01)

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
by: Kaishang Zhang, et al.
Published: (2025-07-01)

Gait in depression: a bibliometric analysis and knowledge mapping of research trends over the past 20 years
by: Shao-Kui Kan, et al.
Published: (2025-08-01)

Fucoidan-decorated metal-zoledronic acid nanocomplexes suppress tumor metastasis by inducing ferroptotic cell death and enhancing cancer immunotherapy
by: Hsin-Ting Tsai, et al.
Published: (2025-06-01)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
by: Tianqi Wang, et al.
Published: (2021-04-01)

THE CHEMOIMMUNOTHERAPY BASED ON DENDRITIC CELLS AND CISPLATIN IN EXPERIMENT
by: Gorbach O. I., et al.
Published: (2014-08-01)

The Application of Multimedia Visualization Platform in Business Management from the Perspective of Supply Chain Management
by: Nuan Wang
Published: (2022-01-01)

The association of serum selenium with serum lipids in US adults
by: Wen Nuan
Published: (2021-01-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series
by: Lingyu Tan, et al.
Published: (2025-01-01)

Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy
by: Yong Zhang, et al.
Published: (2025-08-01)

Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
by: Qiong Zhang, et al.
Published: (2025-01-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
by: Wulyo Rajabto, et al.
Published: (2024-07-01)